Brain-specific genetic ablation of the classical EPOR impairs post-stroke neurogenesis and neuronal survival [45,46] whereas transgenic brain specific overexpression of human EPO is associated with reductions in postischemic infarct volume, brain swelling and functional deficits in a transient stroke model [16]. The gene discussed is EPO; the disease is stroke disorder.